Cost-benefit comparison of hemodialysis access creation in a developing country and North American centres

Cawich, Shamir O; D, Jefferson; Smith, Gerald D; Hoeksema, Greg; Iheonunekwu, Nelson; Hendriks, Frits; Jonge, Laurence van Hanswijck de; Harding, H. E.; Gordon‐Strachan, Georgiana

doi:10.1055/s-0031-1278358

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 13 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite global recommendations and the 'Fistula-First Breakthrough Initiative' [9], the use of TBB-AVF over AVG as a second-line vascular access has been modest [17]. AVG involve the use of prosthetic grafts with inherent risks of infection and thrombosis [18][19][20], in addition to the escalated costs of grafts and associated possible re-interventions to maintain patency [20,21].…”

Section: Introductionmentioning

confidence: 99%

Transposed brachio-basilic arterio-venous fistulae versus prosthetic arteriovenous grafts; mid-term results and a review of literature

Gunawansa¹,

Wolf

2017

Sri Lanka j Surg

View full text Add to dashboard Cite

Introduction With increasing prevalence of chronic kidney disease worldwide, the demand for long-term renal replacement therapy is on the incline. Apart from renal transplantation, this includes sustainable vascular access for long-term haemodialysis, often requiring secondary and tertiary access. Objective To assess the place of Transposed Brachio-Basilic Arterio-Venous Fistula (TBB-AVF) as a second line access compared to prosthetic Aretrio Venous Grafts (AVG), with emphasis on functional patency and access related morbidity and mortality.

show abstract